FDA approves Genentech’s Tecentriq for lung cancer
Roche Holding’s anti-PDL1 immunotherapy MPDL3280A, or atezolizumab, has received priority...
WHAT'S UP IN
Hoffmann-La Roche
Merck Topples Bristol-Myers On Lung Cancer Drug Win
Lung cancer trial results showed a win for Merck and a loss for Bristol-Myers. (tycoon101 –...
